EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE


LinkedIn facebook twitter youtube
News archive

More than 11,000 participants from around the world are expected at the 23rd Congress of the European Hematology Association (EHA) at the Stockholmsmässan, Stockholm, Sweden on June 14-17, 2018, where the latest data on hematology research and development will be presented.

Dr Anna Sureda, Head of Hematology Department, Institut Català d’Oncología (ICO), Spain, explains the expected updates regarding myeloma in the upcoming days.

 







Recent news

» EHA 2021| Daratumumab plus lenalidomide and dexamethasone (D-Rd) shows overall survival benefit in elderly patients with transplant-ineligible newly diagnosed myeloma

» EHA 2021 | Daratumumab maintenance improves Progression-Free Survival (PFS) after autologous stem cell transplantation in myeloma

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy * for Click to select the duration you give consent until.